China National Accord Medicines Corporation Ltd.’s Net Profit Rose 56.3% in First Quarter of 2023

China National Accord Medicines Corporation Ltd. (国药集团一致药业股份有限公司) (000028.SZ) reported a net profit of 460.8 million yuan in the first quarter of 2023, up 56.3% year-on-year.

Meanwhile, the company posted 18.7 billion yuan in revenue, up 9% year-on-year.

At the end of the reporting period, it had 47.9 billion yuan in total assets and 28 billion yuan in total liabilities, with a liability-to-asset ratio of 58.5%.